Advanced Heart Failure Treatment in China

Advanced and refractory heart failure — low ejection fraction (EF ≤ 35%) with symptoms that persist despite optimal medication — can be treated with device therapy, structural and coronary correction, and mechanical support. China's national cardiovascular centers offer the full pathway: CRT, ICD, CCM, CABG and valve intervention, LVAD and heart transplant, typically scheduled within 2–4 weeks.

Coronary artery bypass grafting (CABG): $18,000–$45,000 · vs $100,000+ in the US
Home › Hospitals › Advanced Heart Failure

Quick answer

Advanced heart failure in China is treated as a staged decision path rather than a single procedure. Most care is settled in the device tier — a single-chamber ICD is about $13,750, a dual-chamber ICD about $16,400, CRT-D about $20,600 and CCM about $27,500 — after correcting a reversible cause such as blocked arteries (CABG, $18,000–$45,000) or a faulty valve ($10,000–$15,000). LVAD support is about $123,600 and heart transplant is quoted per case after review. The pathway is for patients with an ejection fraction of 35% or lower who still have symptoms after three or more months of optimal medication. Fu Wai Hospital in Beijing is China's #1 cardiology centre with 18,000+ cardiac surgeries a year, and Anzhen (Beijing), Zhongshan (Shanghai), Guangdong Provincial People's Hospital (Guangzhou) and Xijing (Xi'an) lead device therapy and transplant. Elective device and surgical work is typically scheduled within 2–4 weeks of a multidisciplinary review.

Who this is for

Typically a good fit if

  • Your ejection fraction is 35% or lower and you still have symptoms after three or more months of optimal medication
  • You have been hospitalised more than once for heart failure
  • Your ECG shows left bundle branch block (LBBB) or a widened QRS — the pattern CRT corrects
  • You have severe mitral regurgitation or aortic valve disease alongside the heart failure
  • Your heart failure is ischaemic (blocked arteries) or from dilated cardiomyopathy, and a doctor has said you may need a CRT, ICD, LVAD or transplant

May not be suitable if

  • Your ejection fraction is above 35% and your symptoms are controlled on medication — the standard pathway is medical management, not device or surgical therapy
  • You need intervention within days rather than weeks — elective device and surgical work is typically scheduled two to four weeks after a multidisciplinary review
  • You are looking for a cure — CRT, ICD and CCM manage symptoms and reduce risk, but they do not reverse the underlying disease
  • You want a transplant or LVAD confirmed in advance — eligibility, timing and cost are decided by a multidisciplinary team after your records are reviewed, and cannot be promised by an intermediary
  • Your records are not yet available — a multidisciplinary team cannot classify the cause (ischaemic, valvular, electrical, congenital or cardiomyopathy) without your ECG, echocardiogram, imaging and angiography

Diagnosis

Diagnosis begins with a multidisciplinary (MDT) review of the underlying cause — ischaemic, valvular, electrical dyssynchrony (LBBB or widened QRS), congenital, or cardiomyopathy. ECG, echocardiography, cardiac MRI and coronary angiography are used to determine the cause before a treatment path is chosen.

Treatment Options

Treatment spans the full advanced heart-failure pathway: cardiac resynchronization therapy (CRT-P/CRT-D) and ICD (single, dual or subcutaneous), conduction system pacing (His bundle or left bundle branch) as an alternative to CRT, cardiac contractility modulation (CCM), coronary stenting or bypass, valve repair and replacement (TAVR/TEER), and for refractory cases, LVAD and heart transplant. Supportive measures include ultrafiltration for diuretic-resistant fluid overload and CPAP for obstructive sleep apnoea.

What the Treatment Involves

  1. Multidisciplinary review of the causeBefore travel
    A multidisciplinary team classifies the failure as ischaemic, valvular, electrical (dyssynchrony), congenital, or from cardiomyopathy, using your ECG, echocardiogram, cardiac MRI and angiography. Every later decision depends on this answer.
  2. Sudden-death protection (ICD)Scheduled 2–4 weeks after review
    When the ejection fraction is very low, the immediate risk is a fatal arrhythmia rather than worsening symptoms alone. A single-chamber, dual-chamber or subcutaneous ICD is implanted to shock a dangerous rhythm back to normal — often the first device decision, independent of the other steps.
  3. Rhythm correction or reversible-cause repairSame admission where possible
    If the ECG shows LBBB or a widened QRS, CRT-P — or CRT-D when combined with a defibrillator — re-coordinates the two lower chambers. If there is no conduction problem, the team corrects what is reversible instead: coronary stenting or bypass, valve repair or replacement (TAVR/TEER), or a congenital defect repair.
  4. Contraction support (CCM)If the earlier steps are not enough
    Cardiac contractility modulation strengthens the heart's contraction for patients who still have symptoms after device therapy and where the standard device options are not suitable.
  5. Advanced therapy: LVAD or transplantCoordinated per case
    When the heart no longer responds to any of the above, the options narrow to a left ventricular assist device as a bridge to transplant or as destination therapy, or a heart transplant — coordinated at a transplant centre after a further review.
  6. Recovery and follow-upWeeks to months
    A CABG hospital stay runs 7–10 days with 6–8 weeks to full recovery, and an LVAD or transplant carries a longer recovery and lifelong follow-up. Device patients are monitored remotely; the treating team confirms the schedule for your case.

Typical Costs in China

Coronary artery bypass grafting (CABG) $18,000–$45,000 vs $100,000+ in the US
Heart valve replacement / TAVR $10,000–$15,000 vs $80,000–$120,000 in the US
CRT-D (cardiac resynchronization defibrillator) ≈$20,600 CNY 148,000
ICD (single / dual chamber) ≈$13,750 / ≈$16,400 CNY 99,000 / 118,000
CCM (cardiac contractility modulation) ≈$27,500 CNY 198,000
LVAD (left ventricular assist device) ≈$123,600 CNY 890,000
Heart transplant case-specific quote after case review

Prices are reference ranges; final quotes come from the hospital after case review.

Top Hospitals for Advanced Heart Failure

Foshan Fosun Chancheng Hospital
佛山复星禅诚医院
🏆 Grade III Class A General Hospital, JCI Accredited, #1 Non-Public Hospital in China (Ailibi)
📍 Foshan, Chancheng
View Details →
Fu Wai Hospital
中国医学科学院阜外医院
🏆 #1 Cardiology in China
📍 Beijing, Xicheng
View Details →
Anzhen Hospital
首都医科大学附属北京安贞医院
🏆 Top Cardiovascular Center
📍 Beijing, Chaoyang
View Details →
Zhongshan Hospital (Shanghai)
复旦大学附属中山医院
🏆 Top 3 Cardiology, Top 5 Oncology
📍 Shanghai, Xuhui
View Details →
Guangdong Provincial People's Hospital
广东省人民医院
🏆 Top Cardiology South China
📍 Guangzhou, Yuexiu
View Details →
Xijing Hospital
空军军医大学西京医院
🏆 Top 5 Neurosurgery in China
📍 Xi'an, Beilin
View Details →

Frequently Asked Questions

Which hospital is best for advanced heart failure in China?

Foshan Fosun Chancheng Hospital is a JCI-accredited, Grade III Class A hospital with a dedicated international medical center and multilingual, halal-friendly care — a strong choice for Southeast Asian patients. Fu Wai Hospital (Beijing) is China's #1 cardiology center with 18,000+ cardiac surgeries a year, and Anzhen (Beijing), Zhongshan (Shanghai), Guangdong Provincial People's Hospital (Guangzhou) and Xijing (Xi'an) are leading advanced heart-failure and transplant centers. Different centers lead at different stages, so matching the stage to the hospital matters more than picking a single best name.

How much does CRT or ICD cost in China?

Reference prices: CRT-D about $20,600, single-chamber ICD about $13,750, dual-chamber ICD about $16,400, CCM about $27,500 and LVAD about $123,600. CABG runs $18,000–$45,000 and valve replacement $10,000–$15,000. The final quote depends on the specific device — including whether it is imported or domestic — and your clinical complexity.

How long do I wait for heart failure treatment in China?

Elective procedures are often scheduled within 2–4 weeks of a multidisciplinary review at China's national cardiovascular centers. Timing is confirmed per case after your records are assessed.

What is the difference between CRT, ICD, CCM and LVAD?

An ICD protects against sudden cardiac death by shocking a dangerous rhythm. CRT re-coordinates a poorly synchronised heartbeat and is often combined with an ICD as CRT-D. CCM strengthens the heart's contraction. An LVAD is an implanted pump that supports the heart when device therapy and surgery are no longer enough, usually as a bridge to transplant or as long-term destination therapy.

Am I a candidate for advanced heart failure treatment in China?

This pathway is for patients with an ejection fraction of 35% or lower who still have symptoms after three or more months of optimal medication, have had repeated heart-failure hospitalisations, or whose doctor has said they may need CRT, ICD, LVAD or transplant. A case review with your records confirms eligibility.

Do you offer heart transplant for international patients?

Heart transplant and LVAD are available at China's top cardiac centers, coordinated case by case. Eligibility, timing and cost are confirmed after a multidisciplinary review of your records — a transplant cannot be promised in advance by any intermediary.

Is there an alternative to CRT for a widened QRS?

Yes. Conduction system pacing — at the His bundle or the left bundle branch (LBBP) — stimulates the heart's own conduction pathway instead of placing a lead on the outside of the left ventricle, and can restore near-normal electrical activation. It is performed at China's larger device centres. Whether it suits you rather than standard CRT is decided by the hospital's multidisciplinary team, and the practical question to ask is whether the centre performs it at all.

Does sleep apnoea matter in heart failure?

Yes. Obstructive sleep apnoea is common in heart failure and makes it worse, and CPAP treats the obstruction as supportive care alongside heart-failure treatment. The distinction that matters is central versus obstructive: servo-ventilation is not recommended for patients with reduced ejection fraction and central sleep apnoea, because it was associated with increased mortality.

How this directory is checked

57 Grade 3A hospitals across 13 cities. 20 score 0.9 or above on our verification scale, and 5 were cross-checked against three or more independent sources. Every listing was last verified between 2026-04-06 and 2026-10-13.

What we check, and what we refuse to claim →

🛡️
100% Independent Guidance

We are not affiliated with any hospital. We don't take commissions. Our only goal is finding the right care for you.

Considering treatment for Advanced Heart Failure?

Tell us your diagnosis, scans and timing. We'll match you with the right Grade 3A hospital, compare likely costs, and outline the next practical step — free, no commitment.

Start Free Case Review →
All conditions: Coronary Artery Disease (CABG) Heart Valve Disease Lung Cancer Breast Cancer Liver Cancer Stomach (Gastric) Cancer Colorectal Cancer Brain Tumor Knee Replacement Hip Replacement Spine Surgery & Disc Herniation Parkinson's Disease & DBS Epilepsy IVF & Fertility Treatment LASIK & Vision Correction Cataract Surgery Dental Implants CAR-T Cell Therapy Advanced Heart Failure Cervical Cancer Stroke Rehabilitation
🏠Home 💰Pricing 📋Start
📧Email 💬WhatsApp 📨Telegram
📧 Email us 💬 Chat on WhatsApp 📨 Chat on Telegram 💬 WeChat: chinahospitalguide
🏥

Before You Go...

Finding the right hospital in China can be overwhelming. Let us help — free, no commitment.

⏳ Most cases get a hospital match within 24 hours

Start Free Case Review
No thanks, I'll keep searching